2011 Scrip 100: Wrapping up the EU pharma package
This article was originally published in Scrip
Executive Summary
New EU legislation on pharmacovigilance is now in place, and good progress has been made with a draft law on tackling counterfeit medicines. But political differences among MEPs and ministers mean agreement on the third strand of the EU's "pharmaceutical package" – information to patients – could still be some way off, explains Ian Schofield.